Every recall we track for PFIZER INC — 123 in all — plus the complaints and injury reports the public filed about them.
Pfizer recalls 50mL sodium bicarbonate injection vials with potential lack of sterility. This medication is for prescription use only and may pose infection risks if not properly sterilized.
Pfizer recalls epinephrine injection vials with lot numbers LY3681, LY4360, LY4416 due to lack of sterility assurance. These vials may cause infection if used.
Pfizer recalls 2.4 million units of Bicillin L-A (penicillin G benzathine) injectable suspension with particulates found during visual inspection. Affected lots expire through 2027. No specific remedy is listed in the recall notice.
Pfizer recalls 1.2 million units of Bicillin L-A (penicillin G benzathine) due to particulates found during visual inspection. Affected products have specific NDC codes and expiration dates. Consumers should contact Pfizer for details.
Pfizer recalls 10-vial packages of DOBUTamine injection due to discoloration from cracked vials. Discarded vials may cause unsafe medication use.
Pfizer recalls Buprenorphine Hydrochloride Injection (0.3 mg/mL) due to potential contamination from incomplete crimp seals. This affects specific lots manufactured by Hospira. No remedy is stated in the recall notice.
Pfizer recalls 4.2% sodium bicarbonate injection (5 mEq/10mL) with glass particles that could cause injury during IV use. This product was sold in specific lots and packaging.
Pfizer recalls 1% Lidocaine HCl Injection (50mg/5mL) with glass syringes due to particulate matter risk. This may cause serious injury if injected. Contact Pfizer for return instructions.
Pfizer recalls 4.2% Sodium Bicarbonate Injection with glass particles that could cause injury. This medication is for hospital use only and was packaged in specific lots. Contact Pfizer for details.
Pfizer recalls 2% Lidocaine HCl Injection (100mg/5mL) with glass particulate matter. This could cause injury if injected. Affected units have specific NDC and lot numbers.
Pfizer recalls 15 mg MEKTOVI tablets due to incorrect expiration date on labels. The correct expiration is February 2025, but labels show March 2026. This affects prescription medication.
Pfizer recalls Heparin Sodium 2,000 units per 1,000 mL bags due to potential leakage. This may cause contamination. Check your product details to see if affected.
Pfizer recalls 1.5g vancomycin injections with glass particles that could cause serious injury during injection. Affected lots from 33045BA to 1SEP2023. Stop using immediately.
Pfizer recalls aminophylline injection vials due to a hair complaint in one vial. This medication is prescription-only and distributed by Hospira. Check your vial's lot number and NDC code for affected products.
Pfizer recalls PROPOFOL Injectable Emulsion (100 mL glass vials) due to particulate matter. This may cause serious complications during medical use. Affected units have specific NDC numbers and lot numbers.
Pfizer recalls Propofol Injectable Emulsion vials containing a beetle particulate. This could cause serious injury if injected. Affected vials have NDC 0409-4699-54 and were distributed by Hospira.
Pfizer recalls Accupril 40mg tablets (NDC 0071-0535-23) due to N-nitrosoquinapril levels exceeding safety limits. This may pose a risk of serious health effects. Contact Pfizer for details.
Pfizer recalls Accupril 20mg tablets (NDC 0071-0532-23) due to N-nitrosoquinapril levels exceeding safe limits. This may pose health risks. Contact Pfizer for details.
Pfizer recalls Accupril 10mg tablets (NDC 0071-0530-23) due to N-nitrosoquinapril levels exceeding safe limits. This may pose a health risk. Contact Pfizer for details.
Pfizer recalls Accure: 10mg/12.5mg tablets with potential impurities above safe levels. Rx-only medication distributed by Parke-Davis. Check NDC 0071-0222-23 and lot EA6686 for affected units.
Pfizer recalls Accuretic 20mg/12.5mg tablets due to impurities exceeding safe limits. Affected lots made in Germany with specific NDC and expiration dates. Consumers should contact pharmacy for replacement.
Pfizer recalls Accuretic 20mg/25mg tablets due to impurities exceeding safe levels. Affected lots made in Germany, expiring Feb 2023. Consumers should check NDC 0071-0223-23 and lot number ET6974.
Pfizer recalls 20mg/25mg quinapril-hydrochlorothiazide tablets (Rx only) due to potential impurities that could exceed safe levels. Affected lots manufactured in Germany, expiring Feb 2023.
Pfizer recalls Accure: 10 mg/12.5 mg tablets with potential impurities exceeding safe levels. Consumers with prescription bottles should contact their doctor.
Pfizer recalls Accure: 20mg/12.5mg tablets with potential impurities above safe levels. Rx-only medication distributed by Parke-Davis in Germany. Check NDC 0071-5212-23 and lot FG5381 for affected units.
Pfizer recalls 20 mg/12.5 mg quinapril HCl/hydrochlorothiazide tablets due to impurities that may exceed safe levels. Affected lots manufactured in Germany, expiring March 2023.
Pfizer recalls 20mg/25mg quinapril and hydrochlorothiazide tablets due to potential impurities that could exceed safe levels. This is a prescription-only product distributed by Greenstone LLC.
Pfizer recalls 50mL 5% Dextrose Injection units with potential leak risk. This sterile injection product may cause contamination if the bag leaks.
Pfizer recalls Chantix 1mg tablets with N-nitroso-varenicline impurity above FDA limits. Affected lots and expiration dates listed. Stop using if you have these specific products.
Pfizer recalls Chantix 0.5mg/1mg tablets with N-nitroso-varenicline impurity above FDA limits. Affected lots from January 2023 to August 2021. Stop using if you have these specific lots.
Pfizer recalls Chantix 1mg tablets with N-nitroso-varenicline impurity above FDA limits. Affected lots from June 2023 to September 2021. Stop using if you have these specific lots.
Pfizer recalls Chantix 0.5mg tablets due to potential N-nitroso-varenicline impurity above FDA limits. Affected lots made in Ireland with specific NDC numbers.
Pfizer recalls Chantix tablets with N-nitroso-varenicline impurity above FDA limits. Affected lots expire through January 2023. Stop using and contact Pfizer for details.
Pfizer recalls Chantix 1mg tablets due to potential N-nitroso-varenicline impurity exceeding FDA safety limits. Affected lots made in Ireland, expiring March 2023. Consumers should check NDC codes and contact Pfizer.
Pfizer recalls Chantix 0.5mg tablets due to potential presence of N-nitroso-varenicline impurity above FDA safety limits. Affected lots: 00019213 (exp 31 Jan 2022) and EC6994 (exp May 31, 2023).
